Explore Stanford technologies available for licensing:

Stanford researchers have developed an innovative method for efficiently generating robust lymphatic endothelial cells (iLECs) from human induced pluripotent stem cells (hiPSCs) through transcription factor-based protocols.

Scientists in the De Lecea and Pauly labs optimized ultrasound waveforms that non-invasively modulate brain circuits in freely moving mice.

Researchers at Stanford have developed methods and compositions to provide inducible production of anti-inflammatory cytokines in mesenchymal stem cells (MSCs).

New publication! Read the inventors' newly published Cell Genomics article for this technology (2025): "A peptide display system identifies a potent mutant β-melanocyte-stimulating hormon

Researchers in the Wyss-Coray Lab are investigating a potential therapeutic antibody to treat lysosomal storage disorders and other related neurodegenerative diseases.

Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.

Stanford researchers have developed an innovative, non-invasive therapeutic strategy to treat myocardial fibrosis (MF), a key driver of arrhythmia and heart failure in LMNA-related dilated cardiomyopathy (LMNA-DCM).

Stanford researchers in the Cochran Lab have patented a potential pancreatic cancer therapeutic approach using novel agents that bind tightly to and inhibit a cancer factor called LIF (leukemia inhibitory factor).

SARS-CoV2 is known to gain entry into epithelial cells through the association of its viral spike protein with the ACE2 receptor, which is widely expressed on epithelial cell types.

Stanford researchers have engineered a heterologous system for the high-efficiency production of numerous taxanes and taxane intermediates.

Stanford researchers have developed a first-in-class, non-hormonal male contraceptive that works by targeting a protein found only in developing sperm cells.

Stanford researchers have developed a proteomic biomarker-based algorithm for efficiently diagnosing circadian rhythm and sleep disorders.

Stanford researchers have developed an oral formula and method to reduce the risk of developing food allergies. This patented formula can reduce the risk of food allergy in different age groups when given as part of a normal daily diet.

Trogocytosis is a phenomenon in which one cell transfers small, membrane-bound vesicles called trogocytotic vesicles to another cell.

Researchers at Stanford University have demonstrated rapid and accurate identification of extracellular vesicles (EVs) from different cell lines using an AI-assisted optical platform.